Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series

OBJECTIVES: To present our experience with ammonium tetrathiomolybdate (ATTM) in the decoppering phase treatment of Wilson's disease (WD) with neurological symptoms. METHODS: An uncontrolled longitudinal study was carried out to describe a case series of five patients diagnosed of WD with neuro...

Descripción completa

Detalles Bibliográficos
Autores principales: De Fabregues, Oriol, Viñas, Jaume, Palasí, Antoni, Quintana, Manuel, Cardona, Ignasi, Auger, Cristina, Vargas, Víctor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218247/
https://www.ncbi.nlm.nih.gov/pubmed/32202078
http://dx.doi.org/10.1002/brb3.1596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218247/
https://www.ncbi.nlm.nih.gov/pubmed/32202078
http://dx.doi.org/10.1002/brb3.1596

Ejemplares similares